Side-Branch IPMN Dilemma – How Long and How Often should we Follow?Temel Tirkes
Side branch IPMN (SB-IPMN) of the pancreas has a malignancy rate between 10 and 20%. We hypothesized that surveillance at longer intervals on selected patients with SB-IPMN might be indicated. Methods This is a retrospective study of prospectively collected data of 276 patients presenting from ...
Predicting Progression of Side Branch (SB) Intraductal Papillary Mucinous Neoplasm (IPMN)GERD StageComorbid ConditionsPPI UsageIntroduction: The small intestine exhibits a range of slow wave behaviors, including antegrade and retrograde propagation, coordinating motility. It is typically believed that ...
Side-branch IPMNGiven the malignant potential of main duct intraductal papillary mucinous neoplasm (M-IPMN), surgical resection is generally indicated. With regard to side-branch intraductal papillary mucinous neoplasm (SB-IPMN), resection vs. observation is a topic of debate. Further review of SB-...
Does Splenic Vein Thrombosis Predict Invasive Malignancy in Side-Branch Intraductal Papillary Mucinous Neoplasm (IPMN)?Sweetser, SethVege, Santhi SwaroopClain, Jonathan E.Topazian, Mark D.Official journal of the American College of Gastroenterology | ACG...
Does splenic vein thrombosis predict invasive malignancy in side-branch intraductal papillary mucinous neoplasm (IPMN)?doi:10.1111/j.1572-0241.2008.02010_12.xSethSweetserSanthi SwaroopVegeJonathan EClainMark DTopazianThe American journal of gastroenterology...
Can EUS Differentiate Between Main Duct, Side Branch and Combined Duct IPMN?doi:10.1016/j.gie.2007.03.721BhavaniMopartyandMariMino-KenudsonandGregoryY.LauwersandSDOSGastrointestinal Endoscopy
Background: Pancreatitis can be associated with main-pancreatic duct (MPD) IPMN. This is thought to be related to intermittent obstruction of the MPD with viscous mucin. However, the relationship between pancreatitis and SB-IPMN is not as well described and thus not often considered in the ...
Introduction: The risk of malignancy in branch duct intraductal papillary mucinous neoplasia of the pancreas (BD-IPMN) is controversially debated. An increasing number of studies report on outcomes using the Sendai or Fukuoka consensus criteria for treatment decision-making. The objective of this work...